These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4939556)

  • 1. A double-blind study of the effects of levodopa in Parkinson's disease.
    Nakano KK; Tyler HR
    Neurology; 1971 Oct; 21(10):1069-74. PubMed ID: 4939556
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Parkinson's disease with levodopa and Ro 4-4602.
    Barbeau A; Gillo-Joffroy L; Mars H
    Clin Pharmacol Ther; 1971; 12(2):353-9. PubMed ID: 4930866
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of L-dopa in Parkinson's disease].
    Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
    Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
    [No Abstract]   [Full Text] [Related]  

  • 7. Status of the clinical evaluation of levodopa in the treatment of Parkinson's disease and syndrome.
    Langrall HM; Joseph C
    Clin Pharmacol Ther; 1971; 12(2):323-31. PubMed ID: 4930865
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
    Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
    Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-range motor performance changes in levodopa-treated patients with Parkinson's disease.
    Birdsong JH; McKinney AS
    Neurology; 1974 Feb; 24(2):107-15. PubMed ID: 4855677
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Parkinson's disease with Levodopa.
    Calhoun CL
    J Natl Med Assoc; 1972 Nov; 64(6):516-7 passim. PubMed ID: 4639943
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
    McDowell F; Lee JE; Swift T; Sweet RD; Ogsbury JS; Kessler JT
    Ann Intern Med; 1970 Jan; 72(1):29-35. PubMed ID: 5410397
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of amantadine, placebo, and levodopa in Parkinson's disease.
    Bauer RB; McHenry JT
    Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment of Parkinson's disease with levodopa.
    Martin WE; Loewenson RB; Bilek MK; Resch JA; Baker AB
    J Chronic Dis; 1974 Feb; 27(1):77-93. PubMed ID: 4815073
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa (Larodopa). For the relief of symptoms associated with Parkinson's disease and syndrome.
    Clin Pharmacol Ther; 1970; 11(6):921-4. PubMed ID: 4921295
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensorimotor coordination in Parkinson's disease before and after levodopa therapy.
    Bowen FB; Brady E; Yahr MD
    Neurology; 1973 Oct; 23(10):1101-6. PubMed ID: 4795423
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Parkinson's disease with levodopa].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):543-54. PubMed ID: 4650524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.